
Pharmaceuticals in India
Description
Pharmaceuticals in India
Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Indian pharmaceuticals market registered revenues of $48 billion in 2023, representing a compound annual growth rate (CAGR) of 7.7% between 2018 and 2023.
- The Indian pharmaceuticals market is characterized by the availability of low-cost and high-quality medicines, making it the “pharmacy of the world”.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
- What was the size of the India pharmaceuticals market by value in 2023?
- What will be the size of the India pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up India's pharmaceuticals market?
Table of Contents
46 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the strengths of the leading players?
- 7.4. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Sun Pharmaceutical Industries Ltd
- 8.2. Lupin Ltd
- 8.3. Cipla Ltd
- 8.4. Dr. Reddy's Laboratories Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: India pharmaceuticals market value: $ billion, 2018-23
- Table 2: India pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: India pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: Sun Pharmaceutical Industries Ltd: Key Facts
- Table 5: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 6: Sun Pharmaceutical Industries Ltd: Key Employees
- Table 7: Lupin Ltd: Key Facts
- Table 8: Lupin Ltd: Annual Financial Ratios
- Table 9: Lupin Ltd: Key Employees
- Table 10: Lupin Ltd: Key Employees Continued
- Table 11: Cipla Ltd: Key Facts
- Table 12: Cipla Ltd: Annual Financial Ratios
- Table 13: Cipla Ltd: Key Employees
- Table 14: Dr. Reddy's Laboratories Ltd: Key Facts
- Table 15: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
- Table 16: Dr. Reddy's Laboratories Ltd: Key Employees
- Table 17: India Size of Population (million), 2018-23
- Table 18: India Real GDP (constant 2010 prices, $ billion), 2018-23
- Table 19: India GDP (current prices, $ billion), 2018-23
- Table 20: India Inflation, 2018-23
- Table 21: India Consumer Price Index (absolute), 2018-23
- Table 22: India Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.